URGN
UroGen Pharma Ltd

2,297
Mkt Cap
$999.37M
Volume
751,170.00
52W High
$30.00
52W Low
$3.42
PE Ratio
-6.17
URGN Fundamentals
Price
$21.35
Prev Close
$20.52
Open
$20.68
50D MA
$22.36
Beta
1.12
Avg. Volume
728,235.45
EPS (Annual)
-$2.96
P/B
-8.65
Rev/Employee
$384,672.34
Loading...
Loading...
News
all
press releases
Mark Schoenberg Sells 7,373 Shares of Urogen Pharma (NASDAQ:URGN) Stock
Urogen Pharma (NASDAQ:URGN - Get Free Report) insider Mark Schoenberg sold 7,373 shares of the business's stock in a transaction dated Tuesday, February 3rd. The stock was sold at an average price of...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Urogen Pharma (NASDAQ:URGN) Given Average Rating of "Moderate Buy" by Brokerages
Urogen Pharma (NASDAQ:URGN - Get Free Report) has received an average recommendation of "Moderate Buy" from the nine ratings firms that are presently covering the firm, MarketBeat reports. One...
MarketBeat·3d ago
News Placeholder
Privium Fund Management B.V. Increases Stock Position in Urogen Pharma $URGN
Privium Fund Management B.V. lifted its holdings in Urogen Pharma (NASDAQ:URGN - Free Report) by 82.7% during the third quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·7d ago
News Placeholder
Urogen Pharma (NASDAQ:URGN) Given Buy Rating at D. Boral Capital
D. Boral Capital reissued a "buy" rating and issued a $33.00 target price on shares of Urogen Pharma in a report on Friday...
MarketBeat·15d ago
News Placeholder
Harel Insurance Investments & Financial Services Ltd. Trims Holdings in Urogen Pharma $URGN
Harel Insurance Investments & Financial Services Ltd. decreased its holdings in shares of Urogen Pharma (NASDAQ:URGN - Free Report) by 47.5% in the 3rd quarter, according to its most recent Form 13F...
MarketBeat·19d ago
News Placeholder
Urogen Pharma (NASDAQ:URGN) Shares Down 6.5% - What's Next?
Urogen Pharma (NASDAQ:URGN) Stock Price Down 6.5% - Time to Sell...
MarketBeat·1mo ago
News Placeholder
D. Boral Capital Reiterates "Buy" Rating for Urogen Pharma (NASDAQ:URGN)
D. Boral Capital restated a "buy" rating and set a $33.00 target price on shares of Urogen Pharma in a research report on Monday...
MarketBeat·1mo ago
News Placeholder
Urogen Pharma $URGN Shares Purchased by Squarepoint Ops LLC
Squarepoint Ops LLC raised its position in Urogen Pharma (NASDAQ:URGN - Free Report) by 187.8% during the second quarter, according to the company in its most recent 13F filing with the Securities...
MarketBeat·2mo ago
News Placeholder
Urogen Pharma Target of Unusually Large Options Trading (NASDAQ:URGN)
Urogen Pharma (NASDAQ:URGN - Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock investors acquired 20,427 call options on the company. This represents an...
MarketBeat·2mo ago
News Placeholder
Urogen Pharma (NASDAQ:URGN) Stock Price Up 6.4% - Still a Buy?
Urogen Pharma (NASDAQ:URGN) Stock Price Up 6.4% - Still a Buy...
MarketBeat·2mo ago
<
1
2
...
>

Latest URGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.